Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -64.109% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCN(CC)CCNC(=O)CSc1c2c(nc3cc(Cl)ccc13)CCCC2
b Cc1nc(SCC(=O)NCC2CCCO2)c2c3c(sc2n1)CCC3
c COc1ccc(OC)c(C2C=C(c3ccc(C)c(C)c3)Nc3nnnn32)c1
Answer: a. CCN(CC)CCNC(=O)CSc1c2c(nc3cc(Cl)ccc13)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)CCNC(=O)CSc1c2c(nc3cc(Cl)ccc13)CCCC2
CCN(CC)CCNC(=O)CSc1c2c(nc3cc(Cl)ccc13)CCCC2
2-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]-N-[2-(diethylamino)ethyl]acetamide